Effects of recombinant factor VIIa on thrombin generation and thromboelastography in a patient with dabigatran-associated intracranial hemorrhage Jennifer L. AronRobert GosselinSimon Mantha Letter 22 March 2013 Pages: 76 - 79
Dabigatran-associated subdural hemorrhage: using thromboelastography (TEG®) to guide decision-making Ron NeyensNicole BohmJulio Chalela Report 11 May 2013 Pages: 80 - 83
Thrombosis on a mechanical mitral valve anticoagulated with dabigatran Stephanie CoulterKarla Campos Report 28 June 2013 Pages: 84 - 86
Evidence behind quality of care measures for venous thromboembolism and atrial fibrillation G. EyminA. K. Jaffer OriginalPaper 11 September 2013 Pages: 87 - 96
Short-term central venous catheter complications in patients with sickle cell disease who undergo apheresis Mahmut YeralCan BogaIlknur Kozanoglu OriginalPaper 16 March 2013 Pages: 97 - 101
A transition of P2Y12 antagonists for acute coronary syndrome: benefits, risks and costs Wei Eric WangHongyong WangChunyu Zeng OriginalPaper 13 April 2013 Pages: 102 - 106
Elevated lipoprotein(a) levels and homozygous human platelet antigen 1b (HPA-1b) genotype are risk factors for intrauterine growth restriction (IUGR) Andrea GerhardtNadja HoweRainer Bernd Zotz OriginalPaper 27 March 2013 Pages: 107 - 117
In vitro comparison of the novel, dual-acting FIIa/FXa-inhibitor EP217609C101, unfractionated heparin, enoxaparin, and fondaparinux in preventing cardiac catheter thrombosis Anja KaeberichUwe RaazAxel Schlitt OriginalPaper 03 July 2013 Pages: 118 - 130
Pharmacodynamic effects of EV-077 in patients with diabetes mellitus and coronary artery disease on aspirin or clopidogrel monotherapy: results of an in vitro pilot investigation Fabiana RolliniAntonio Tello-MontoliuDominick J. Angiolillo OriginalPaper 14 August 2013 Pages: 131 - 138
The impact of anti-inflammatory cytokines provoked by CD163 positive macrophages on ventricular functional recovery after myocardial infarction Takao SatoTomoki KameyamaHiroshi Inoue OriginalPaper 20 July 2013 Pages: 139 - 147
Propensity for young reticulated platelet recruitment into arterial thrombi Robert D. McBane IICatherine GonzalezWaldemar E. Wysokinski OriginalPaper 05 May 2013 Pages: 148 - 154
D-dimer levels predict ischemic and hemorrhagic outcomes after acute myocardial infarction: a HORIZONS-AMI biomarker substudy Wouter J. KikkertBimmer E. ClaessenGeorge D. Dangas OriginalPaper 08 August 2013 Pages: 155 - 164
Platelet activity in Chinese obese adolescents with and without insulin resistance Huimin LuShundong LeiNi Chen OriginalPaper 02 April 2013 Pages: 165 - 170
Warfarin use in atrial fibrillation patients at low risk for stroke: analysis of the Michigan Anticoagulation Quality Improvement Initiative (MAQI2) Geoffrey D. BarnesScott KaatzJames B. Froehlich OriginalPaper 08 May 2013 Pages: 171 - 176
The effect of CYP2C9, VKORC1 and CYP4F2 polymorphism and of clinical factors on warfarin dosage during initiation and long-term treatment after heart valve surgery Vacis TatarunasVaiva LesauskaiteRimantas Benetis OriginalPaper 16 May 2013 Pages: 177 - 185
Retinal artery occlusions in children Aruna DharmasenaSimon Wallis OriginalPaper 26 February 2013 Pages: 186 - 189
Effectiveness of antiplatelet therapy in atherosclerotic disease: comparing the ASA low-response prevalence in CVD, CAD and PAD Saskia H. MevesThomas HummelHorst Neubauer OriginalPaper 04 April 2013 Pages: 190 - 201
Safety and efficacy of simultaneous bilateral carotid angioplasty and stenting Yongkun LiWenshan SunXinfeng Liu OriginalPaper 04 April 2013 Pages: 202 - 209
Method validation and clinical utility of chromogenic factor VIII assay compared to one-stage assay Wilmare GouwsElsabie BothaAdele Visser OriginalPaper 16 March 2013 Pages: 210 - 215
The pharmacology of novel oral anticoagulants Tracy A. DeWaldRichard C. Becker OriginalPaper 17 July 2013 Pages: 217 - 233
Structure–function relationships of factor Xa inhibitors: implications for the practicing clinician Benjamin A. SteinbergRichard C. Becker OriginalPaper 01 September 2013 Pages: 234 - 241